WHO ICTRP trial
A Dose response study in patients with mild to moderate hypertension.
CTRI/2011/04/001682 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2011/04/001682 |
|---|---|
| Public title | A Dose response study in patients with mild to moderate hypertension. |
| Scientific title | A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension |
| Primary sponsor | Novartis Healthcare Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India;Argentina;Canada;Hungary;India;Poland;Republic of Korea;Romania;Slovakia;United States of America |
| Conditions | Health Condition 1: null- Systolic Hypertension |
| Interventions | Intervention1: LCZ696: The LCZ 696 compound comprises the molecular moieties AHU377 and valsartan, and sodium and water molecules in the ratio of 1:1:3:2:5 respectively. Dosage: 200 mg qd for one week, thereafter they will be up-titrated to… |
| Registration date | Apr 19, 2011 |
| Target size | 910 |
| Secondary IDs | CLCZ696A2223;NCT01281306 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: